CEO exercised or converted 5,438 ZBH derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 6, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 10, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001757216-26-000008
Added to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerZIMMER BIOMET HOLDINGS, INC. Reporting personIvan Tornos RelationshipDirector, Officer Officer titleChairman, President and CEO SecurityRestricted Stock Units TableDerivative (Table II) Transaction dateMar 6, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Each RSU represents a contingent right to receive one share of Company common stock.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.